Atlas Trials

Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

Clinical trial NCT04825262 · COMPLETED

Trial details

NCT number
NCT04825262
Sponsor
Singapore General Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Kidney Transplant RejectionKidney Transplant; Complications
Start date
2021-02-01
Primary completion
2024-01-16
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.